HR 2319 Passed House Re-checks Congress.gov for new actions and updates the bill's status, and fills in any sponsors, committees, or related bills that are missing. It does not re-pull sponsors/cosponsors/committees/related — those rarely change — and it skips all work if nothing has changed upstream, so it's cheap to click.
Women and Lung Cancer Research and Preventive Services Act of 2025
Summary
This bill directs the Secretary of Health and Human Services, working with the Defense and Veterans Affairs departments, to review the current status of lung cancer research, screening, and awareness efforts—particularly as they affect women and underserved populations. The review must identify gaps in research, opportunities for improved collaboration across federal agencies, and strategies to expand access to lung cancer screening and prevention services. The HHS Secretary is also directed to develop recommendations for a national lung cancer screening strategy and public education campaign focused on early detection. The Secretary must submit a comprehensive report to Congress within two years of the bill's enactment detailing findings and recommendations.
AI-generated plain-language summary of the bill text — neutral, and may be imperfect. See the full text below for the exact wording.
Sponsor (1)
2 cosponsors
Money behind the sponsor
Top reported contributors to Brendan F. Boyle’s campaign committee (2024 cycle) — who funds the bill’s sponsor, not a claim about this bill. Data from FEC.
- ROCKET COMPANIES $9,900
- THE DASCHLE GROUP $9,300
- MASSMUTUAL $8,000
- CORNERSTONE GOVERNMENT AFFAIRS $7,300
- GOLDMAN SACHS $6,850
Organizations whose employees gave the most — itemized individual contributions grouped by the donor’s reported employer (FEC Schedule A). Full finance for Brendan F. Boyle → · Outside spending →
Actions (13)
- Apr 22, 2026 Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 380. · senate
- Apr 21, 2026 Motion to reconsider laid on the table Agreed to without objection. · house
- Apr 21, 2026 On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H3020) · house
- Apr 21, 2026 Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H3020)
- Apr 21, 2026 DEBATE - The House proceeded with forty minutes of debate on H.R. 2319. · house
- Apr 21, 2026 Considered under suspension of the rules. (consideration: CR H3020-3021) · house
- Apr 21, 2026 Mrs. Harshbarger moved to suspend the rules and pass the bill. · house
- Nov 18, 2025 Placed on the Union Calendar, Calendar No. 332. · house
- Nov 18, 2025 Reported by the Committee on Energy and Commerce. H. Rept. 119-382. · house
- Apr 29, 2025 Ordered to be Reported by Voice Vote. · house
- Apr 29, 2025 Committee Consideration and Mark-up Session Held · house
- Mar 25, 2025 Referred to the House Committee on Energy and Commerce. · house
- Mar 25, 2025 Introduced in House
More bills on these subjects (8)
Other bills that carry the most legislative subjects in common with this one (topical discovery — distinct from the procedural related bills above).
Text versions (4)
Bills are re-published as they move (Introduced → Reported → Engrossed → Enrolled …). Each stage below is a separate text; pick two to see what changed. Data from Congress.gov.
Full text
AN ACT
To direct the Secretary of Health and Human Services to conduct a review to evaluate the status of research on lung cancer in women and underserved populations, and for other purposes.
Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the “Women and Lung Cancer Research and Preventive Services Act of 2025”.
SEC. 2. INTERAGENCY REVIEW TO EVALUATE AND IDENTIFY OPPORTUNITIES FOR THE ACCELERATION OF RESEARCH ON LUNG CANCER IN WOMEN AND UNDERSERVED POPULATIONS, GREATER ACCESS TO PREVENTIVE SERVICES, AND STRATEGIC PUBLIC AWARENESS AND EDUCATION CAMPAIGNS.
(a) In General.—The Secretary of Health and Human Services, in consultation with the Secretary of Defense and the Secretary of Veterans Affairs, shall conduct an interagency review to evaluate the status of, and identify opportunities for the acceleration of research related to—
(1) research on lung cancer in women;
(2) research on lung cancer in underserved populations that meet the eligibility criteria for lung cancer screening as recommended by the United States Preventive Services Task Force;
(3) access to lung cancer preventive services; and
(4) strategic public awareness and education campaigns on lung cancer.
(b) Content.—The review and recommendations under subsection (a) shall include—
(1) a review and comprehensive report on the outcomes of previous research, the status of existing research activities, and knowledge gaps related to lung cancer in women and underserved populations in all agencies of the Federal Government;
(2) opportunities for collaborative, interagency, multidisciplinary, and innovative research, that would—
(A) encourage innovative approaches to eliminate knowledge gaps in research on lung cancer in women;
(B) evaluate environmental and genomic factors that may be related to the etiology of lung cancer in women; and
(C) foster advances in imaging technology and techniques to improve risk assessment, diagnosis, treatment, and the simultaneous utilization of other preventive services and activities;
(3) opportunities regarding the development of a national lung cancer screening strategy to expand access to such screenings, particularly among women and underserved populations; and
(4) opportunities regarding the development of a national public education and awareness campaign on—
(A) lung cancer in women and underserved populations; and
(B) the importance of early detection of lung cancer.
(c) Report.—Not later than two years after the date of the enactment of this Act, the Secretary of Health and Human Services shall submit to Congress a report on the review conducted under subsection
(a).
Passed the House of Representatives April 21, 2026.
Attest:
Clerk. 119th CONGRESS
2d Session
H. R. 2319
AN ACT
To direct the Secretary of Health and Human Services to conduct a review to evaluate the status of research on lung cancer in women and underserved populations, and for other purposes.
Comments